About Ventricular Assist Devices
Heart failure is a medical condition wherein the heart loses its ability to pump enough blood to circulate throughout the body. In such a condition, a patient can survive by having heart transplantation with a healthy heart. A VAD is a medical device that is used to support the patient with either acute or chronic cardiac functional deterioration. It is a mechanical pump implanted in a patient affected by heart failure to help the heart’s weakened ventricle to pump blood into the aorta or throughout the body.
TechNavio's analysts forecast the Global Ventricular Assist Devices market to grow at a CAGR of 12.04 percent over the period 2014-2019.
Covered in this Report
The Global Ventricular Assist Devices market is divided into three segments based on product type: Left Ventricular Assist Devices, Right Ventricular Assist Devices, and Bi-ventricular Assist Devices.
TechNavio's report, Global Ventricular Assist Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Ventricular Assist Devices market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• APAC
• EMEA
Key Vendors
• Abiomed
• HeartWare International
• Thoratec
Other Prominent Vendors
• Berlin Heart
• Cardiac Assist
• Jarvik Heart
• Reliantheart
• Sun Medical Technology Research
Market Driver
• Shortage of Heart Donors
• For a full, detailed list, view our report
Market Challenge
• Presence of Alternative Treatments
• For a full, detailed list, view our report
Market Trend
• Increased Use of Ventricular Assist Devices for BTT Therapy
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Product
07.1 Global LVAD Market
07.2 Global BiVAD Market
07.3 Global RVAD Market
08. Market Segmentation by Application
09. Geographical Segmentation
09.1 VAD Market in the Americas
09.1.1 Market Size and Forecast
09.2 VAD Market in the EMEA Region
09.2.1 Market Size and Forecast
09.3 VAD Market in the APAC Region
09.3.1 Market Size and Forecast
10. Buying Criteria
11. Pipeline Products
11.1 Key Information about Pipeline Products
11.1.1 ReliantHeart HeartAssist 5 VAD System
11.1.2 HeartMate III LVAS
11.1.3 HeartMate PHP
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Vendor Analysis 2014
18.2.1 Product Portfolio Matrix
18.3 Other Prominent Vendors
19. Key Vendor Analysis
19.1 ABIOMED
19.1.1 Key Facts
19.1.2 Business Overview
19.2 HeartWare
19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 Product Segmentation
19.2.4 Geographical Segmentation by Revenue 2013
19.2.5 Business Strategy
19.2.6 Recent Developments
19.2.7 SWOT Analysis
19.2.8 Segmentation by Revenue 2014
19.2.9 Segmentation by Revenue 2013 and 2014
19.2.10 Geographical Presence
19.2.11 Recent Developments
19.2.12 SWOT Analysis
19.3 Thoractec
19.3.1 Key Facts
19.3.2 Business Overview
19.3.3 Product Segmentation by Revenue 2013
19.3.4 Product Segmentation by Revenue 2012 and 2013
19.3.5 Geographical Segmentation by Revenue 2013
19.3.6 Business Strategy
19.3.7 SWOT Analysis
20. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Ventricular Assist Device Market 2014–2019 (US$ million)
Exhibit 3: Global VAD Market Segmentation by Product
Exhibit 4: Global VAD Market Segmentation by Product
Exhibit 5: Global LVAD Market 2014-2019 (US$ million)
Exhibit 6: Global BiVAD Market 2014-2019 (US$ million)
Exhibit 7: Global RVAD Market 2014-2019 (US$ million)
Exhibit 8: Global VAD Market Segmentation by Product 2014-2019
Exhibit 9: Global VAD Market Segmentation by Application
Exhibit 10: Global VAD Market Segmentation by Application 2014
Exhibit 11: Global VAD Market by Geographical Segmentation 2014
Exhibit 12: VAD Market in the Americas 2014-2019 (US$ million)
Exhibit 13: VAD Market in the EMEA Region 2014-2019 (US$ million)
Exhibit 14: VAD Market in the APAC Region 2014-2019 (US$ million)
Exhibit 15: Global VAD Market by Geographical Segmentation 2014-2019
Exhibit 16: Snapshot of Pipeline for VAD
Exhibit 17: Global VAD Market by Vendor Share 2014
Exhibit 18: HeartWare: Product Segmentation
Exhibit 19: HeartWare: Geographical Segmentation by Revenue 2013
Exhibit 20: ABIOMED: Segmentation by Revenue 2014
Exhibit 21: ABIOMED: Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 22: ABIOMED: Geographical Presence
Exhibit 23: Thoratec: Product Segmentation by Revenue 2013
Exhibit 24: Thoratec: Product Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 25: Thoratec: Geographical Segmentation by Revenue 2013
